See the Complete Picture.
Published loading...Updated

MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin ...

Summary by Enid News & Eagle
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and delivery devices for patients with endocrine and orphan lung diseases, will…

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Enid News & Eagle broke the news in on Monday, June 9, 2025.
Sources are mostly out of (0)